Patents by Inventor Daniel A. Erlanson

Daniel A. Erlanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended tethering approach for rapid identification of ligands
    Patent number: 6919178
    Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.
    Type: Grant
    Filed: November 21, 2001
    Date of Patent: July 19, 2005
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Daniel A. Erlanson, Andrew C. Braisted, Robert McDowell, John Prescott
  • Small molecule inhibitors of caspases
    Patent number: 6878743
    Abstract: The present invention provides compounds having formula (I): and pharmaceutically acceptable derivatives thereof, wherein A, B, D, E, G, J, n, and R1 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof as caspase inhibitors and for the treatment of disorders caused by excessive apoptotic activity.
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: April 12, 2005
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Ingrid Choong, Matthew Burdett, Warren DeLano, Daniel Erlanson, Dennis Lee, Willard Lew
  • Methods for identifying allosteric sites
    Publication number: 20040014140
    Abstract: The present invention relates to exosites and methods for identifying exosites in protein targets. The present invention also relates to methods for identifying allosteric sites and identifying compounds that bind therein.
    Type: Application
    Filed: April 8, 2003
    Publication date: January 22, 2004
    Inventors: Daniel A. Erlanson, Stig K. Hansen, Jeanne Hardy, Joni Lam, Thomas O'Brien
  • Methods for identifying compounds that modulate enzymatic activity
    Publication number: 20040005632
    Abstract: The present invention relates to the use of “tethering” to identify compounds that modulate enzymatic activity.
    Type: Application
    Filed: February 25, 2003
    Publication date: January 8, 2004
    Inventors: Daniel A. Erlanson, Robert S. McDowell, Stig Hansen
  • Small molecule inhibitors of caspases
    Publication number: 20030114447
    Abstract: The present invention provides compounds having formula (I): 1
    Type: Application
    Filed: September 17, 2002
    Publication date: June 19, 2003
    Inventors: Ingrid Choong, Matthew Burdett, Warren DeLano, Daniel Erlanson, Dennis Lee, Willard Lew
  • Novel ligands and libraries of ligands
    Publication number: 20030013125
    Abstract: The present invention provides compounds and libraries of compounds having formula (I): 1
    Type: Application
    Filed: May 10, 2002
    Publication date: January 16, 2003
    Inventors: Andrew C. Braisted, Daniel A. Erlanson, Jeffrey W. Jacobs
  • Extended tethering approach for rapid identification of ligands
    Publication number: 20020150947
    Abstract: The invention concerns a method for rapid identification and characterization of binding partners for a target molecule, and for providing binding partners with improved binding affinity. More specifically, the invention concerns an improved tethering method for the rapid identification of at least two binding partners that bind near one another to a target molecule.
    Type: Application
    Filed: November 21, 2001
    Publication date: October 17, 2002
    Inventors: Daniel A. Erlanson, Andrew C. Braisted, Robert McDowell, John Prescott
  • Tosylproline analogs as thymidylate synthase inhibitors
    Patent number: 6143776
    Abstract: Tosylproline analogs of formula I, methods of making them, pharmaceutical compositions containing them, and methods for their use. The compounds are thymidylate synthase inhibitors; and are useful as anti-tumor agents and as anti-parasitics, anti-bacterials, anti-fungals, and anti-virals.
    Type: Grant
    Filed: February 2, 2000
    Date of Patent: November 7, 2000
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventor: Daniel A. Erlanson